Search details
1.
Factors associated with COVID-19-related death using OpenSAFELY.
Nature
; 584(7821): 430-436, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32640463
2.
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.
Br J Clin Pharmacol
; 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38589944
3.
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records.
Br J Clin Pharmacol
; 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38531661
4.
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England.
Clin Infect Dis
; 75(1): e1120-e1127, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34487522
5.
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
PLoS Med
; 19(1): e1003871, 2022 01.
Article
in English
| MEDLINE | ID: mdl-35077449
6.
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
Lancet
; 397(10286): 1711-1724, 2021 05 08.
Article
in English
| MEDLINE | ID: mdl-33939953
7.
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY.
BMC Med
; 20(1): 243, 2022 07 05.
Article
in English
| MEDLINE | ID: mdl-35791013
8.
Recording of 'COVID-19 vaccine declined': a cohort study on 57.9 million National Health Service patients' records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021.
Euro Surveill
; 27(33)2022 08.
Article
in English
| MEDLINE | ID: mdl-35983770
9.
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts.
Ann Rheum Dis
; 80(7): 943-951, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33478953
10.
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.
Euro Surveill
; 26(11)2021 03.
Article
in English
| MEDLINE | ID: mdl-33739254
11.
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY.
Wellcome Open Res
; 8: 70, 2023.
Article
in English
| MEDLINE | ID: mdl-37346822
12.
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.
Lancet Reg Health Eur
; 34: 100741, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37927438
13.
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
BMJ Open
; 13(1): e066164, 2023 01 31.
Article
in English
| MEDLINE | ID: mdl-36720568
14.
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.
Lancet Public Health
; 8(5): e364-e377, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37120260
15.
Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics.
BMJ Med
; 2(1): e000392, 2023.
Article
in English
| MEDLINE | ID: mdl-37303488
16.
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using OpenSAFELY.
BMJ Ment Health
; 26(1)2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37714668
17.
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY.
BMJ Med
; 2(1): e000276, 2023.
Article
in English
| MEDLINE | ID: mdl-36936265
18.
Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults' primary care records in England through OpenSAFELY.
Elife
; 122023 07 27.
Article
in English
| MEDLINE | ID: mdl-37498081
19.
OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England.
Wellcome Open Res
; 7: 191, 2022.
Article
in English
| MEDLINE | ID: mdl-35966958
20.
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
BMJ
; 379: e071932, 2022 11 16.
Article
in English
| MEDLINE | ID: mdl-36384890